These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 32439311)
1. Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions. Ponnusamy L; Natarajan SR; Thangaraj K; Manoharan R Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188379. PubMed ID: 32439311 [TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Cao W; Li J; Hao Q; Vadgama JV; Wu Y Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936 [TBL] [Abstract][Full Text] [Related]
3. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells. Cai H; Zhang Y; Han TK; Everett RS; Thakker DR Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511 [TBL] [Abstract][Full Text] [Related]
4. Selective AMPK activator leads to unfolded protein response downregulation and induces breast cancer cell death and autophagy. Nascimento Mello AL; Sagrillo FS; de Souza AG; Costa ARP; Campos VR; Cunha AC; Imbroisi Filho R; da Costa Santos Boechat F; Sola-Penna M; de Souza MCBV; Zancan P Life Sci; 2021 Jul; 276():119470. PubMed ID: 33831423 [TBL] [Abstract][Full Text] [Related]
5. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity. Zou YF; Xie CW; Yang SX; Xiong JP Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400 [TBL] [Abstract][Full Text] [Related]
6. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling. Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659 [TBL] [Abstract][Full Text] [Related]
7. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation. Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947 [TBL] [Abstract][Full Text] [Related]
8. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties. MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450 [TBL] [Abstract][Full Text] [Related]
9. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349 [TBL] [Abstract][Full Text] [Related]
10. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities. Vazirian M; Nabavi SM; Jafari S; Manayi A Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216 [TBL] [Abstract][Full Text] [Related]
11. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138 [TBL] [Abstract][Full Text] [Related]
12. Acetylsalicylic Acid Governs the Effect of Sorafenib in Hammerlindl H; Ravindran Menon D; Hammerlindl S; Emran AA; Torrano J; Sproesser K; Thakkar D; Xiao M; Atkinson VG; Gabrielli B; Haass NK; Herlyn M; Krepler C; Schaider H Clin Cancer Res; 2018 Mar; 24(5):1090-1102. PubMed ID: 29196297 [No Abstract] [Full Text] [Related]
13. Promise and challenges for direct small molecule AMPK activators. Olivier S; Foretz M; Viollet B Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352 [TBL] [Abstract][Full Text] [Related]
14. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics. Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514 [TBL] [Abstract][Full Text] [Related]
15. Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome. Hill JL; Kobori N; Zhao J; Rozas NS; Hylin MJ; Moore AN; Dash PK J Neurochem; 2016 Oct; 139(1):106-19. PubMed ID: 27379837 [TBL] [Abstract][Full Text] [Related]
16. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells. Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093 [TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase. Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819 [TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. Shieh JM; Chen YC; Lin YC; Lin JN; Chen WC; Chen YY; Ho CT; Way TD J Agric Food Chem; 2013 Jul; 61(26):6366-75. PubMed ID: 23777448 [TBL] [Abstract][Full Text] [Related]
20. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells. Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]